Clinical Handbook of Psychotropic Drugs: Comprehensive Guide for Mental Health Professionals

Get quick and comprehensive information on psychotropic drugs for adults with the Clinical Handbook of Psychotropic Drugs. This trusted reference and working tool is designed for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

Independent, Unbiased, and Up-to-Date Information

This handbook provides independent, unbiased, and up-to-date information on psychotropic drugs, packed with unique and easy-to-read comparison charts and tables. These charts cover essential information such as dosages, side effects, pharmacokinetics, and interactions, giving you a quick overview of treatment options.

Comprehensive Coverage of Medication Classes

The handbook covers all classes of medication, including on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more. Each class of drug is summarized in concise, bulleted information, making it easy to find the information you need.

Convenient and Accessible Format

The Clinical Handbook of Psychotropic Drugs features instantly recognizable icons and is printed in full color throughout, allowing you to quickly find the information you seek. Additionally, downloadable patient information sheets are available as printable PDF files, making it easy to share with your patients.

New in This Edition

• Antidepressants chapter includes a new section on the NMDA receptor antagonist/CYP2D6 inhibitor combination product (dextromethorphan/bupropion; Auvelity extended-release tablets)
• Antipsychotics updates include revised Clozapine monitoring tables which now also contain monitoring requirements for patients with or without non-benign ethnic neutropenia
• Mood Stabilisers sections on Lithium and Anticonvulsants extensively revised
• Dementia chapter includes a new section on Lecanemab (Leqembi), a fast-track FDA approved treatment for Alzheimer’s disease
• Treatment of Substance Use Disorders includes revisions to Buprenorphine dosing section to include a rapid micro-induction method (Bernese method) that allows treatment to start without waiting for patient to be in withdrawal
• Unapproved treatments of Psychiatric Disorders, Natural Health Products, and Pharmacogenetic chapters all substantially revised
• New formulations and trade names include: Invega Hafyera (paliperidone long-acting 6-monthly IM injection), Subutex (buprenorphine sublingual tablets), Quviviq (daridorexant tablets)

Stay up-to-date with the latest information on psychotropic drugs with the Clinical Handbook of Psychotropic Drugs. This essential reference is a must-have for every mental health professional.

Publisher: HOGRE

Edition: 25th edition (June 30, 2023)

Language: English

Format: Spiral-bound, 480 pages

ISBN-10: 0889376328

ISBN-13: 978-0889376328